Guest guest Posted April 15, 2005 Report Share Posted April 15, 2005 http://www.mssociety.org.uk/news_events/news/research/further_evidenc e.html Further evidence needed after disappointing Aimspro trial results, say neurologists 06.04.05 The results from the recently completed small study of Aimspro (goat serum) in optic neuritis (a common symptom or model for MS) were presented at a scientific meeting last week. They make it clear that the main measures used to evaluate its effect were negative. Tertiary outcomes, while not showing a benefit when compared to placebo, showed some interesting results. A spokesman for the MS Society said, " We note that this is the first time clinical trial data involving Aimspro in MS has been formally presented to the medical community. In the light of this new information, we want to highlight how important it is that research findings are responsibly disseminated and the need for peer- reviewed, published research information. Reports in the media can sometimes be limited or exaggerated and may lead to disappointment. The Society awaits publication of the results of this clinical trial. " Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.